Juliana Chan The Chinese University of Hong KongHong Kong, China

Professor Juliana Chan is a physician scientist specialised in diabetes and clinical pharmacology. Since 1995, she led a multidisciplinary team to establish the Hong Kong Diabetes Register accompanied by a biobank in pursuit of precision medicine. In 2007, her team designed the web-based Joint Asia Diabetes Evaluation Technology to promote data-driven personalised care and collaborative research in Asia. These programs have provided the template for a territory-wide risk assessment and management and created the population-based Hong Kong Diabetes Surveillance Database demonstrating the 50-70% decline in death rate in 2000-2016. Professor Chan has published 500 original articles and 20 book chapters. She is a committee member of several landmark studies and local research and healthcare policies related to diabetes and non-communicable diseases. She is a recipient of the American Diabetes Association Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes, and she leads a Lancet Commission on Diabetes.

2 APRIL 2023

Time Session
08:30
10:00
CKD and Diabetes: Treatment and Prevention Update
Alessia Fornoni Chairperson University of MiamiUnited States
Muh Geot Wong Chairperson University of SydneyAustralia
  • CKD with Diabetes vs. Diabetic Nephropathy
    Hans-Joachim Anders Speaker hjanders@med.uni-muenchen.deLMU MUnichGermany
  • Treatment 1 (SGLT2, GLP1)
    Julia Weinmann Menke Speaker Medical Center of Johannes Gutenberg University MainzGermany
  • Treatment 2 (Finrenone, etc.)
    Vuddhidej Ophascharoensuk Speaker Chiang Mai UniversityThailand
  • Prevention of DKD
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
Plenary Hall 1

30 MARCH 2023

Time Session
11:00
13:00
Clinical Trials Course: Designing and Running Your Trial
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Establishing and Conducting Your Trial
    Hong Zhang Speaker Peking University First HospitalChina
  • Q and A
  • Global Representation in Large Trials
    Hernan Trimarchi Speaker HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Q and A
  • Innovations in Trial Conduct
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
MR 110

31 MARCH 2023

Time Session
17:00
18:00
*This session is for In-Person delegates only
Poster Session 1
  • Acute Kidney Injury
    Letizia De Chiara Moderator letizia.dechiara@unifi.itUniversità degli studi di FirenzeItaly
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 1
    Chirag Parikh Moderator chirag.parikh@jhmi.eduJohns Hopkins UniversityUnited States
  • Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
    Marques Ng Moderator The Chinese University of Hong KongHong Kong, China
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 1
    Chuan-Ming Hao Moderator Huashan Hospital Fudan UniversityChina
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 2
    Vivek Kumar Moderator PGIMER, ChandigarhIndia
  • Chronic Kidney Disease Diagnosis, Classification and Progression 1
    Sydney Tang Moderator The University of Hong KongHong Kong, China
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 1
    Matthias Kretzler Moderator kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 1
    Donnah Franceska De Leon Moderator
  • Clinical Glomerulonephritis 2
    Warangkana Pichaiwong Moderator Rajavithi HospitalThailand
  • Covid-19 and AKI
    Neil Boudville Moderator Sir Charles Gairdner HospitalAustralia
  • Covid-19 and KF (Kidney Failure)
    Sarinya Boongird Moderator Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand
  • Diabetic Kidney Disease, Drugs and Treatments 1
    John Cijiang He Moderator United States
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 1
    Abduzhappar Gaipov Moderator Nazarbayev University School of MedicineKazakhstan
  • Epidemiology, Outcomes and Health Services Research in Dialysis 1
    Geraldo Bezerra da Silva Jr Moderator University of FortalezaBrazil
  • Experimental Models- Glomerulonephritis
    Donnah Franceska De Leon Moderator
  • Haemodialysis, Haemodiafiltration and Vascular Access 1
    Anil Agarwal Moderator akagarwalmd@gmail.comUniversity of California San Francisco at Fresno and VA Central California Health Care SystemUnited States
  • Kidney in Pregnancy and Post-Partum
    Liz Lightstone Moderator Imperial College London and Hammersmith HospitalUnited Kingdom
  • Kidney Transplantation and Transplant Immunology 1
    Eric Rondeau Moderator Sorbonne Université Hopital TenonFrance
  • Kidney Transplantation and Transplant Immunology 2
    Ahmed Kalebi Moderator Ahmed Kalebi ConsultancyKenya
  • Online Learning
    Amnart Chaiprasert Moderator Thailand
  • Other AKI
    Watanyu Parapiboon Moderator Maharat Nakhonratchasima HospitalThailand
  • Other CKD 1
    Juliana Chan Moderator The Chinese University of Hong KongHong Kong, China
  • Peritoneal Dialysis 1
    Xueqing Yu Moderator Guangdong Provincial People's HospitalChina
  • Social Media
    Sibel Bek Moderator Kocaeli University HospitalTurkey
  • Special Challenges in the Burden and Management of CKD in Developing Countries
    Kearkiat Praditpornsilpa Moderator kearkiat@hotmail.comThailand
Ballroom 2-3-4-Exhibition Hall